Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors

Weixin Bei,1,2,* Shuhui Dong,1,2,* Guoying Liu,1,3,4,* Lanfeng Lin,2,5,* Yaofei Jiang,1,2 Nian Lu,1,2 Wangzhong Li,1,2 Hu Liang,1,2 Yanqun Xiang,1,2 Weixiong Xia1,2 1Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China; 2...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Bei W, Dong S, Liu G, Lin L, Jiang Y, Lu N, Li W, Liang H, Xiang Y, Xia W
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Dove Medical Press 2024-07-01
Seri Bilgileri:	Cancer Management and Research
Konular:	metastatic nasopharyngeal carcinoma chemotherapy pd-1 immune checkpoint inhibitors second-line treatment strategies
Online Erişim:	https://www.dovepress.com/efficacy-and-safety-of-re-challenging-pd-1-inhibitors-in-second-line-t-peer-reviewed-fulltext-article-CMAR
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!